Nicole Hunt discusses the upcoming U.S. Supreme Court case that will decide access to the abortion drug Mifeprex. The case challenges the FDA's loosening of regulations for obtaining the drug, arguing that it should be held to the same safety standards as other medications. The outcome of the case will have significant implications for the abortion debate and may impact the 2024 election. Oral arguments will likely be scheduled for the spring, with a decision expected by the end of June.